NCT04877665

Brief Summary

Reference intervals (RIs) of thyroid-stimulating hormone (TSH) and free thyroxine (FT4) are age, assay and population specific. Currently, the age and assay-specific RIs for TSH are not available for children under two years of age. This study aimed to establish reference intervals for serum concentrations of TSH and FT4 in healthy children aged 1-24 months as per CLSI C28-A3 guidelines.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
131

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2019

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 5, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
Last Updated

May 7, 2021

Status Verified

May 1, 2021

Enrollment Period

8 months

First QC Date

May 5, 2021

Last Update Submit

May 5, 2021

Conditions

Keywords

Thyroid Stimulating HormoneReference IntervalChildrenPakistan

Outcome Measures

Primary Outcomes (1)

  • Establishing Reference Intervals for Thyroid Stimulating Hormone in Children under the age of two years

    This study aimed to establish reference intervals for serum concentrations of TSH and FT4 in healthy children aged 1-24 months as per CLSI C28-A3 guidelines.

    August 2018 to March 2019

Eligibility Criteria

Age1 Month - 24 Months
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Healthy children from 1 to 24 months

You may qualify if:

  • Healthy children from 1 to 24 months

You may not qualify if:

  • recent illness, hospitalization, medication and maternal history of thyroid-related diseases, recent abnormal total leucocyte or neutrophil count in the medical record or positive microbial cultures, history of any diagnosed disease or infection, history of hospitalization during the previous four weeks, congenital hypothyroidism or transient congenital hypothyroidism, history of maternal thyroid illness, or any medications with potential influences on the thyroid function, such as amiodarone, anti-epileptic drugs, glucocorticoids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Aga Khan University

Karachi, Sindh, 3500, Pakistan

Location

MeSH Terms

Conditions

Hypothyroidism

Condition Hierarchy (Ancestors)

Thyroid DiseasesEndocrine System Diseases

Study Officials

  • Siraj Muneer

    Aga Khan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident

Study Record Dates

First Submitted

May 5, 2021

First Posted

May 7, 2021

Study Start

August 1, 2018

Primary Completion

March 30, 2019

Study Completion

March 30, 2019

Last Updated

May 7, 2021

Record last verified: 2021-05

Locations